Literature DB >> 9311502

Arterial endothelin-1 level in pulmonary emphysema and interstitial lung disease. Relation with pulmonary hypertension during exercise.

T Yamakami1, O Taguchi, E C Gabazza, M Yoshida, T Kobayashi, H Kobayashi, H Yasui, H Ibata, Y Adachi.   

Abstract

This study was undertaken to assess the arterial plasma levels of endothelin-1 (ET-1) and their relationship with pulmonary haemodynamic and gas exchange variables during exercise in patients with emphysema and interstitial lung disease (ILD). Incremental cycle ergometry was performed in all patients up to maximal capacity. At rest, arterial ET-1 levels were higher in emphysema (1.86 +/- 0.35 pg.mL-1; p < 0.02) and ILD (1.75 +/- 0.25 pg.mL-1; p < 0.03) patients than in controls (1.35 +/- 0.18 pg.mL-1). Emphysema (2.08 +/- 0.26 versus 1.70 +/- 0.40 pg.mL-1) and ILD (1.98 +/- 0.21 versus 1.67 +/- 0.02 pg.mL-1) patients with pulmonary hypertension (PH) presented significantly (p < 0.05) higher arterial ET-1 levels than those without. At rest, arterial ET-1 levels were significantly correlated with mean pulmonary arterial pressure (Ppa) in both ILD (r = 0.8, p = 0.01) and emphysema (r = 0.5, p = 0.03) patients. During exercise, the arterial ET-1 levels were significantly correlated with arterial oxygen (Pa,O2) (r = -0.6, p = 0.04), alveolar-arterial oxygen difference (r = 0.8, p = 0.01), and Ppa (r = 0.6, p = 0.04) in ILD patients, but not in those with emphysema. In brief, the results of this study suggest that arterial endothelin-1 is markedly increased in interstitial lung disease and emphysema patients, and that, it is related to the exercise-induced exacerbation of pulmonary hypertension in patients with interstitial lung disease, but not in those with emphysema.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9311502     DOI: 10.1183/09031936.97.10092055

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  5 in total

1.  Therapy in stable chronic obstructive pulmonary disease patients with pulmonary hypertension: a systematic review and meta-analysis.

Authors:  Xuesong Chen; Shaowen Tang; Kouying Liu; Qinling Li; Hui Kong; Xiaoning Zeng; Weiping Xie; Hong Wang
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

2.  Adhesion molecules, endothelin-1 and lung function in seven population-based cohorts.

Authors:  E C Oelsner; T D Pottinger; K M Burkart; M Allison; S G Buxbaum; N N Hansel; R Kumar; E K Larkin; L A Lange; L R Loehr; S J London; G T O'Connor; G Papanicolaou; M F Petrini; D Rabinowitz; S Raghavan; S Redline; B Thyagarajan; R P Tracy; J B Wilk; W B White; S S Rich; R G Barr
Journal:  Biomarkers       Date:  2013-04-05       Impact factor: 2.658

3.  Plasma endothelin-1 and vascular endothelial growth factor levels and their relationship to hemodynamics in idiopathic pulmonary fibrosis.

Authors:  Corey E Ventetuolo; Steven M Kawut; David J Lederer
Journal:  Respiration       Date:  2012-08-03       Impact factor: 3.580

4.  Exhaled and arterial levels of endothelin-1 are increased and correlate with pulmonary systolic pressure in COPD with pulmonary hypertension.

Authors:  Pierluigi Carratu; Cristina Scoditti; Mauro Maniscalco; Teresa Maria Seccia; Giuseppe Di Gioia; Felice Gadaleta; Rosa Angela Cardone; Silvano Dragonieri; Paola Pierucci; Antonio Spanevello; Onofrio Resta
Journal:  BMC Pulm Med       Date:  2008-09-26       Impact factor: 3.317

Review 5.  Systematic review and meta-analysis of pulmonary hypertension specific therapy for exercise capacity in chronic obstructive pulmonary disease.

Authors:  Jinkyeong Park; Ju Hee Song; Dong-Ah Park; Jae Seoung Lee; Sang-Do Lee; Yeon-Mok Oh
Journal:  J Korean Med Sci       Date:  2013-07-31       Impact factor: 2.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.